Webinars - Myriad RBM
 
 

Webinars

Upcoming Webinars

There are no upcoming webinars at this time, please check back soon.


Previous Webinars

Simoa Webinar

Detecting the Undetectable: Development and Validation of Ultrasensitive Simoa-based Assays to Reproducibly Measure Immune System Regulatory Proteins in Human Blood Samples

Quanterix’s ultrasensitive single molecule array (Simoa) technology enables the accurate measurement of protein biomarkers that were previously difficult or even impossible to detect in blood samples.

Access the On-Demand Webinar
 


A Myriad RBM Webinar

Vectra® DA: A Multi-Biomarker Blood Test for Assessing Disease Activity in Patients with Rheumatoid Arthritis

This presentation will summarize: the development and validation of Vectra DA, the basis for its clinical utility, and how Vectra DA can be helpful to clinical trials of pharmaceutical agents.

Access the On-Demand Webinar
 


lung-webinar-tn

Detection of Subclinical Interstitial Lung Disease: A Potential Role for Targeted Blood Biomarker Profiling

The general purpose of our translational research studies is to identify clinical tools for the detection of subclinical parenchymal lung disease.

Access the On-Demand Webinar
 


TruCulture

Standardized Assays for Personalized Immune Response Monitoring

This online seminar provides an overview of research published in Immunity that demonstrates progress in the standardization of assays for personalized immune response monitoring.

Access the On-Demand Webinar
 


SMA-MAP: A multiplexed immunoassay biomarker panel for Spinal Muscular Atrophy

Learn about an approach used for developing biomarkers in rare, pediatric disease and gain insights on current and future utility of the SMA-MAP panel in SMA and other neuromuscular research.

Access the On-Demand Webinar


Translating Preclinical Pharmacology in Clinical Activity

Watch to learn how Myriad RBM’s products and services were used by VentiRx to compare potency, define PK/PD relationships, identify potential clinical biomarkers of VTX-2337 activity and establish a Minimal Anticipated Biological Effect Level (MABEL) for the initial clinical trial.

Access the On-Demand Webinar


Drug Induced Kidney Injury Biomarkers: Data From Four Species

Translatability and Utility in Drug Safety Studies and Kidney Disease Research – Find out how this suite of solutions, developed in conjunction with the Predictive Safety Testing Consortium (PSTC), can help you expedite translational development from pre-clinical animal studies to early clinical testing.

Access the On-Demand Webinar


Kidney MAPs®: Biomarker Panels for Detecting Kidney Injury

Get the low-down on a recent set of publications by the Predictive Safety Testing Consortium (PSTC) on qualifying a panel of biomarkers for preclinical studies of nephrotoxicity using RBM’s Rat Kidney® MAP. Also, see data demonstrating the utility of the biomarkers for human kidney injury.

Access the On-Demand Webinar


TruCulture®: Simplicity in Ex Vivo Immune Monitoring

Discover what TruCulture is and how it’s helping drug developers make better decisions.

Access the On-Demand Webinar